President
The president hasn’t yet dismissed Makary, the person said, asking not to be identified because discussions are private. The Trump administration is also mulling additional personnel changes at the FDA, according to people familiar with the deliberations.
Makary’s time as FDA commissioner has been marked by high employee
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
